Ping An Biomedical Approves $312,500 Capital Increase and 100M High-Vote Shares
Ping An Biomedical boosted authorized capital from US$50,000 to US$312,500 by adding 4.2 billion shares and introduced 100 million Class B shares carrying 100 votes each. The board secured approval to exchange 12.25 million Class A shares for Class B shares with INSPIRETECH and consolidate shares at up to a 1,000-to-1 ratio.
1. Authorised Capital Increase and Share Classes
At the AGM on March 18, 2026, shareholders approved raising authorised share capital from US$50,000 (800 million ordinary shares) to US$312,500 (5 billion ordinary shares) by adding 4.2 billion shares at US$0.0000625 par. They reclassified all 4.9 billion existing shares as Class A and created 100 million Class B shares with 100 votes each.
2. Share Exchange with INSPIRETECH
Shareholders authorized the board to repurchase 12.25 million Class A shares from INSPIRETECH in exchange for issuing 12.25 million Class B shares, converting part of INSPIRETECH’s stake into high-vote shares while preserving its overall shareholding.
3. Share Consolidation and MAA Amendments
The board received authority to consolidate Class A and Class B shares on up to a 1,000-to-1 basis within one year, rounding up fractional entitlements, and to amend the company’s memorandum and articles of association to reflect the consolidated share structure.